Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism.
about
Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharideDC-SIGN (CD209) mediates dengue virus infection of human dendritic cellsFlavivirus cell entry and membrane fusionRecent advances in DENV receptorsCarbohydrate-related inhibitors of dengue virus entryReplication in cells of hematopoietic origin is necessary for Dengue virus disseminationAutophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralizationHeat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cellsThe four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cellsRecent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and PathogenesisDengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- StimulationHigher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD DeficiencyA dengue receptor as possible genetic marker of vector competence in Aedes aegyptiSmall interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virusSerotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptorLipopolysaccharide and phorbol 12-myristate 13-acetate both impair monocyte differentiation, relating cellular function to virus susceptibilityRoles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infectionInhibition of dengue virus entry and multiplication into monocytes using RNA interferencePathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveBovine CD14 gene characterization and relationship between polymorphisms and surface expression on monocytes and polymorphonuclear neutrophils.Mapping protein interactions between Dengue virus and its human and insect hosts.Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cellsActivation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells.Progress in the identification of dengue virus entry/fusion inhibitorsRNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cellsAn emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach.Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease.Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients.Lectin switching during dengue virus infectionSHP-1-dependent macrophage differentiation exacerbates virus-induced myositisProductive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis.Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs.C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.Dengue virus receptor.IFITMs restrict the replication of multiple pathogenic virusesDengue virus entry as target for antiviral therapy.Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.
P2860
Q24538617-BA7F5472-4E17-4B96-A591-67371A9AC2BFQ24673466-8C2EEE2E-41A2-4F0B-BA26-AD52DCB6D596Q26852458-CAD8BF11-D6DD-4F6E-B3B4-B3C79CF3834FQ26863203-3DB7F1A3-3398-4F48-B24F-72467C5566CAQ26864413-FA487C85-DEC1-4F81-B2E8-93DF8A3D693FQ27347892-B0BD6B3B-A4D3-454C-B5F2-B6AB8F96F36DQ27468834-DBC3AAD3-2FAF-482B-9AC8-1391B109892BQ27469442-8995671B-2CEB-4A09-834A-81580E7DA260Q27477510-DB218EA7-25CE-4E81-8755-99FC992FC021Q27477646-7436A8B7-D319-4C3D-8EFD-E4CB1CBA58EFQ27481475-FDB2F6EC-CA53-4E87-AF5A-47BDEA8B1617Q27485240-BB8A2F10-FCE0-418E-AB8C-F8CB87644039Q27486539-31A2E426-1494-424E-9BAD-3E2FDE746E71Q27490952-8F7684C3-3928-47DA-B294-FE5AA120FE9CQ28289980-A1493B81-DF1A-425B-A4DC-A352D221C7FFQ28347789-173238AC-98DD-4E71-8321-A50449067D9AQ28475368-D65F273A-CD63-4147-A26F-85BF5FE11A0BQ28478179-7C5B2509-2F1F-4BBD-93AF-555907DCEA75Q29994529-C7EAFB01-9D72-46EA-A06B-1546156402E5Q33358970-14912FBF-51E1-4911-9475-C1271EB22C6EQ33831759-16124A25-D9AA-4234-B91A-93DF2088DC42Q33955239-D2F1A99B-189C-41B5-86B6-D18E5EADF7C0Q33988856-59B8DC75-B52B-4BAC-982B-C24C66836C09Q34054616-5EF45AD2-1044-460D-BECA-EEE8F98F19B2Q34212157-AC27C350-FD59-414E-A1F7-44F34619E323Q34353489-29177DAF-42AB-4FDB-8F09-2198301B2DC6Q34552933-4A1BDE6B-51EF-44B6-A154-4119FA827993Q34634859-8B4A99B7-59A7-4894-9F15-9E611B8EE320Q34746720-6D13061C-0129-46BE-B4BD-63B2EEB8921AQ34785824-3BBD2CC8-BF83-4D44-81F7-9ACD0A951BB7Q35000894-75F941D9-A820-4DDD-94DF-156A51974DE4Q35183147-B698E1AE-3E1A-47E3-B0F3-1243B17F8811Q35192749-4038E43D-DCC2-46E8-BE61-432142E04F5CQ35867080-77639734-4BB9-4C87-AD75-CC88583F1B9CQ36280060-AEA02B4B-7DB7-4CA5-8447-9D4138F819E6Q37625156-4128BF71-1FC8-49C6-88BF-BE93C66DCBFFQ38002405-4822CBE9-F30A-4D10-B6D6-D8B3DD703087Q38146443-EE2B7F44-ACCE-485D-B8C8-CFA0CB1B8BBFQ40289267-A8C43DFE-19E3-4A82-8127-06CCB9497384Q49920855-0CE75001-61BD-4F07-A67C-C3DAE6359100
P2860
Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Bacterial lipopolysaccharide i ...... via a CD14-dependent mechanism
@nl
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@ast
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@en
type
label
Bacterial lipopolysaccharide i ...... via a CD14-dependent mechanism
@nl
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@ast
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@en
prefLabel
Bacterial lipopolysaccharide i ...... via a CD14-dependent mechanism
@nl
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@ast
Bacterial lipopolysaccharide i ...... ia a CD14-dependent mechanism.
@en
P2860
P921
P3181
P1433
P1476
Bacterial lipopolysaccharide i ...... via a CD14-dependent mechanism
@en
P2860
P304
P3181
P577
1999-04-01T00:00:00Z